Fox Run Management’s Kymera Therapeutics KYMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11,120	Closed	-$332K	–	966
2024 Q2	$332K	Buy	+11,120	New	+$332K	0.06%	534
2024 Q1	–	Sell	-8,135	Closed	-$207K	–	940
2023 Q4	$207K	Buy	+8,135	New	+$207K	0.05%	623